Katie Mackenzie

Good morning, everyone, and welcome to the Elixinol Business Update Investor Webinar. On our call today, we have Gavin Evans, the Chair; Natalie Butler, Executive Director and CEO; and Adam Dimitropoulos, the CFO. And my name is Katie Mackenzie, Investor Relations for Elixinol.

The presentation today will run for about 15, 20 minutes, and then we will open up for Q&A. [Operator Instructions]

And now I would like to hand over to Gavin Evans. Over to you, Gavin.

Natalie Butler
CEO & Executive Director

Gavin, you're on mute. We've got you back now. We can hear you.

Gavin Evans

You can hear me?

Natalie Butler
CEO & Executive Director

Yes.

Gavin Evans

Sorry about that. It's the age-old issue of being on mute in this day and age. So apologies for that. Thank you. Great to be here. Just getting to where I need to. So yes, thank you, Katie. Good morning, everyone. It's great to be here and engaging with our shareholders again and especially off the back of some solid momentum in the market over the last few days.

The purpose of today's webinar is twofold: Firstly, we want to expand on the exciting news of our new national distribution agreement with Priceline, which we announced last Friday. And this is really significant operating milestone for the company and has clearly created some buzz in the market. Natalie will go through that in more detail shortly. Secondly, we wanted to provide a clear overview of our operational and capital structure reset prior to the upcoming AGM. We're aware that the Notice of Meeting for the